Ulcerative colitis (UC) is an inflammatory bowel disease primarily affecting the colon and rectum. Current therapies, including corticosteroids, immunosuppressants, biologics, and 5-aminosalicylates, remain limited by suboptimal efficacy, adverse effects, and drug resistance, highlighting the need for safer and more effective therapeutic agents. In the present study, we identified QX-6 as a novel small-molecule compound with potent anti-inflammatory activity. In lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and bone marrow-derived macrophages (BMDMs), QX-6 markedly reduced the expression of pro-inflammatory cytokines and reactive oxygen species (ROS) production. Multi-omics analyses further revealed significant enrichment of ferroptosis related pathways following QX-6 treatment. Consistently, QX-6 regulated the expression of ferroptosis-related proteins, including NRF2, HMOX1, GCLM, GPX4, FTL, and SLC40A1, while reducing ROS accumulation and lipid peroxidation and ameliorating ferroptosis-associated mitochondrial alterations in macrophages. Moreover, pharmacological induction of ferroptosis partially reversed the inhibitory effects of QX-6 on inflammatory cytokine expression and lipid peroxidation, further supporting the involvement of ferroptosis-related signaling in its anti-inflammatory activity. In vivo, QX-6 treatment significantly alleviated colon shortening in experimental models of UC, with the 120 mg·kg−1 dose showing the strongest protective effect, surpassing that of the positive control drug 5-aminosalicylic acid. Overall, these findings demonstrate that QX-6 exerts significant anti-inflammatory effects both in vitro and in vivo, and suggest that it may serve as a promising therapeutic candidate for UC.
- Article type
- Year
- Co-author
Open Access
Original Article
Issue
Glycosyltransferases (GTs) are key enzymes in the glycosylation of plant secondary metabolites, primarily catalyzing the transfer of a sugar moiety from an activated donor to a specific acceptor molecule. Triterpenoid saponins, an abundant and diverse group of natural products, are composed of triterpenoid aglycones and one or more sugar chains, under the catalysis of GTs. Phytolacca Radix is a traditional Chinese medicine containing over 40 triterpenoid saponins with pharmacological values. However, the identification of glycosyltransferases related to triterpenoid saponin synthesis from Phytolacca species remains scarce. In this study, a novel glycosyltransferase, PamUGT, was identified from Phytolacca americana. PamUGT exhibits catalytic activity toward 28-/30-COOH of pentacyclic triterpenoids, and it exhibits a preference for the C-30 position when both carboxyl groups are available. To our knowledge, PamUGT is the first glycosyltransferase identified in Phytolacca species that can catalyze triterpenoids. Further analysis of substrate specificity revealed that PamUGT catalyzes the glycosylation of a wide range of compounds, including triterpenoids, flavonoids, diterpenoids, alkaloids, and phenolic acids. Our findings identify a highly promiscuous glycosyltransferase, offering a valuable enzymatic tool for modifying diverse natural products.
京公网安备11010802044758号